Studyportals
Certificate On Campus

Clinical Vaccine Development and Biomanufacturing University of Oxford

Highlights
Tuition fee
1425 GBP / full
1425 GBP / full
Unknown
Tuition fee
1425 GBP / full
1425 GBP / full
Unknown
Duration
4 days
Duration
4 days
Apply date
Unknown
Unknown
Apply date
Unknown
Unknown
Start date
Unknown
Start date
Unknown
Campus location
Oxford, United Kingdom
Campus location
Oxford, United Kingdom
Taught in
English
Taught in
English

About

The Clinical Vaccine Development and Biomanufacturing course offered by University of Oxford was designed and developed in close collaboration with leading clinicians, veterinarians and industrial partners who conduct clinical trials.

Overview

What you will learn

The Clinical Vaccine Development and Biomanufacturing course offered by University of Oxford aims to provide:

  • An overview of pre-clinical testing and the pathway from pre-clinical testing to field trials.
  • A more detailed discussion of vaccine immunogenicity, testing vaccine immunogenicity in the field and the need for correlates of immune protection. The different phases of vaccine testing from Phase I to IV.
  • An overview of the development of veterinary vaccines.
  • An introduction to the principles and conduct of Good Clinical Practice.

Programme Structure

The program focuses on:

  • Human and veterinary vaccinology
  • The clinical vaccine development process
  • Vaccine types 
  • Adjuvants for vaccines in clinical trials
  • Immunomonitoring and immune correlates
  • ICH Guidelines of Good Clinical Practice
  • Biomanufacturing
  • Technology transfer
  • The safety testing of novel biological and viral vaccines
  • Quality by Design analytics
  • Clinical trials in Africa
  • GMP upstream and downstream processes 
  • Process Development
  • Taking lab discoveries into manufacture - a COVID19 case study
  • Manufacturing case study: Oxford BioMedica expansion due to Covid pandemic
  • Regulatory vaccine trial applications in the UK, Europe and beyond
  • Accelerating outbreak response vaccine trials
  • The importance of post-vaccination surveillance.
  • Statistical considerations
  • Ethical considerations
  • The importance of post-vaccination surveillance
  • Designing and coordinating large, multi-centre, Phase III clinical trials in different age cohorts

Key information

Duration

  • Full-time
    • 4 days

Start dates & application deadlines

Language

English

Delivered

On Campus

Campus Location

  • Oxford, United Kingdom

What students do after studying

Join for free or log in to access our complete career info list.

Academic requirements

We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.

English requirements

We are not aware of any English requirements for this programme.

Other requirements

General requirements

  • Our course participants will therefore reflect the diversity of the subject and be from business, academic, clinical and veterinary backgrounds. 
  • The course will be of particular interest to research scientists, programme managers, clinical trial coordinators, nurses, physicians and veterinarians. 
  • The course will be accessible to people already working in the field or to those who wish to enter the field.

Tuition Fees

Tuition fees are shown in and the most likely applicable fee is shown based on your nationality.
  • International

    Non-residents
    1425 GBP / full
    1425 GBP / full
  • Domestic

    Citizens or residents
    1425 GBP / full
    1425 GBP / full

Living costs

Oxford

United Kingdom
939 - 1530 GBP / month

The living costs include the total expenses per month, covering accommodation, public transportation, utilities (electricity, internet), books and groceries.

Funding

Other interesting programmes for you

Our partners

Clinical Vaccine Development and Biomanufacturing
University of Oxford
Clinical Vaccine Development and Biomanufacturing
-
University of Oxford

Wishlist

Go to your profile page to get personalised recommendations!